PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0137200
Background HIV infection results in damage to the gastrointestinal (GI) tract, microbial translocation and immune activation. These are not completely...
MUCOSAL IMMUNE RECONSTITUTION | ACTIVATION | THERAPY | MULTIDISCIPLINARY SCIENCES | IN-VIVO | REGULATORY T-CELLS | DOUBLE-BLIND | COAGULATION | HUMAN-IMMUNODEFICIENCY-VIRUS | MICROBIAL TRANSLOCATION | DECLINE | Anti-HIV Agents - pharmacology | HIV Infections - diet therapy | Humans | Middle Aged | Aging - drug effects | Male | Combined Modality Therapy | Probiotics - pharmacology | Dysbiosis - complications | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV Infections - microbiology | Inflammation - complications | Inflammation - diet therapy | Aging - immunology | Gastrointestinal Microbiome - drug effects | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | Probiotics - therapeutic use | Aged | Longitudinal Studies | CD4-Positive T-Lymphocytes - drug effects | Probiotics | Usage | Patient outcomes | Clinical trials | Dosage and administration | Inflammation | Research | Drug therapy | Protein binding
MUCOSAL IMMUNE RECONSTITUTION | ACTIVATION | THERAPY | MULTIDISCIPLINARY SCIENCES | IN-VIVO | REGULATORY T-CELLS | DOUBLE-BLIND | COAGULATION | HUMAN-IMMUNODEFICIENCY-VIRUS | MICROBIAL TRANSLOCATION | DECLINE | Anti-HIV Agents - pharmacology | HIV Infections - diet therapy | Humans | Middle Aged | Aging - drug effects | Male | Combined Modality Therapy | Probiotics - pharmacology | Dysbiosis - complications | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV Infections - microbiology | Inflammation - complications | Inflammation - diet therapy | Aging - immunology | Gastrointestinal Microbiome - drug effects | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | Probiotics - therapeutic use | Aged | Longitudinal Studies | CD4-Positive T-Lymphocytes - drug effects | Probiotics | Usage | Patient outcomes | Clinical trials | Dosage and administration | Inflammation | Research | Drug therapy | Protein binding
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 10/2016, Volume 17, Issue 10, pp. 1639 - 1639
Recently the tryptophan pathway has been considered an important determinant of HIV-1 infected patients' quality of life, due to the toxic effects of its...
HIV-1 | Tryptophan | CNS | Neopterin | IDO | HAND | QUINOLINIC ACID LEVELS | PERMEABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROBIOTA | SERUM | neopterin | CHEMISTRY, MULTIDISCIPLINARY | HIV-INFECTION | IMMUNE ACTIVATION | CENTRAL-NERVOUS-SYSTEM | tryptophan | IRRITABLE-BOWEL-SYNDROME | BRAIN | BLOOD
HIV-1 | Tryptophan | CNS | Neopterin | IDO | HAND | QUINOLINIC ACID LEVELS | PERMEABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROBIOTA | SERUM | neopterin | CHEMISTRY, MULTIDISCIPLINARY | HIV-INFECTION | IMMUNE ACTIVATION | CENTRAL-NERVOUS-SYSTEM | tryptophan | IRRITABLE-BOWEL-SYNDROME | BRAIN | BLOOD
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e109791
Introduction: During HIV infection the severe depletion of intestinal CD4(+) T-cells is associated with microbial translocation, systemic immune activation,...
LYMPHOID-TISSUE | MULTIDISCIPLINARY SCIENCES | POSITIVE PATIENTS | AIDS | DEPLETION | HIV-1-INFECTED PATIENTS | RESTORATION | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL SIV HOSTS | MICROBIAL TRANSLOCATION | GUT MUCOSA | HIV Infections - blood | Immunohistochemistry | Cell Proliferation | Intestines - pathology | HIV Infections - virology | Humans | Middle Aged | Male | Interleukin-17 - biosynthesis | Viral Load - immunology | Antiretroviral Therapy, Highly Active | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Lipopolysaccharides - blood | Lymphocyte Activation - immunology | Th17 Cells - immunology | Adult | HIV Infections - drug therapy | Interferon-gamma - biosynthesis | Infection | Antiviral agents | Clinical trials | Inflammation | T cells | Health aspects | Enzyme-linked immunosorbent assay | Cell proliferation | Therapy | rRNA 16S | Laboratories | CD8 antigen | Mucosa | Helper cells | Lymphocytes T | Infections | Activation | CD14 antigen | Blood | Lipopolysaccharides | Cell activation | Microorganisms | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Intestine | Human immunodeficiency virus--HIV | Pretreatment | Endoscopy | Drug therapy | Digestive tract | Public health | Chronic illnesses | Immune system | Translocation | Antiretroviral drugs | Digestive system | Markers | Gene expression | Antiretroviral therapy | CD4 antigen | Medicine | Studies | Cytometry | Pathology | Infectious diseases | Acquired immune deficiency syndrome | HIV | Human immunodeficiency virus
LYMPHOID-TISSUE | MULTIDISCIPLINARY SCIENCES | POSITIVE PATIENTS | AIDS | DEPLETION | HIV-1-INFECTED PATIENTS | RESTORATION | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL SIV HOSTS | MICROBIAL TRANSLOCATION | GUT MUCOSA | HIV Infections - blood | Immunohistochemistry | Cell Proliferation | Intestines - pathology | HIV Infections - virology | Humans | Middle Aged | Male | Interleukin-17 - biosynthesis | Viral Load - immunology | Antiretroviral Therapy, Highly Active | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Lipopolysaccharides - blood | Lymphocyte Activation - immunology | Th17 Cells - immunology | Adult | HIV Infections - drug therapy | Interferon-gamma - biosynthesis | Infection | Antiviral agents | Clinical trials | Inflammation | T cells | Health aspects | Enzyme-linked immunosorbent assay | Cell proliferation | Therapy | rRNA 16S | Laboratories | CD8 antigen | Mucosa | Helper cells | Lymphocytes T | Infections | Activation | CD14 antigen | Blood | Lipopolysaccharides | Cell activation | Microorganisms | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Intestine | Human immunodeficiency virus--HIV | Pretreatment | Endoscopy | Drug therapy | Digestive tract | Public health | Chronic illnesses | Immune system | Translocation | Antiretroviral drugs | Digestive system | Markers | Gene expression | Antiretroviral therapy | CD4 antigen | Medicine | Studies | Cytometry | Pathology | Infectious diseases | Acquired immune deficiency syndrome | HIV | Human immunodeficiency virus
Journal Article
AIDS Research and Therapy, ISSN 1742-6405, 04/2016, Volume 13, Issue 1, p. 21
Despite the combined antiretroviral therapy has improved the length and quality of life of HIV infected patients, the survival of these patients is always...
Premature aging | HIV | Cardiovascular diseases | CARV | INTIMA-MEDIA THICKNESS | INFECTIOUS DISEASES | ENDOTHELIAL DYSFUNCTION | ANKLE-BRACHIAL INDEX | ANTIRETROVIRAL THERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS | cARV | PERCUTANEOUS CORONARY INTERVENTION | AIDS-DEFINING EVENTS | ACUTE MYOCARDIAL-INFARCTION | IMMUNE ACTIVATION | INFECTED PATIENTS | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Anti-HIV Agents - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Antiretroviral Therapy, Highly Active - adverse effects | Viremia - drug therapy | Viremia - complications | HIV Infections - complications | Aging | Cardiovascular Diseases - epidemiology | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Cardiovascular disease | Patients | Human immunodeficiency virus--HIV
Premature aging | HIV | Cardiovascular diseases | CARV | INTIMA-MEDIA THICKNESS | INFECTIOUS DISEASES | ENDOTHELIAL DYSFUNCTION | ANKLE-BRACHIAL INDEX | ANTIRETROVIRAL THERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS | cARV | PERCUTANEOUS CORONARY INTERVENTION | AIDS-DEFINING EVENTS | ACUTE MYOCARDIAL-INFARCTION | IMMUNE ACTIVATION | INFECTED PATIENTS | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Anti-HIV Agents - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Antiretroviral Therapy, Highly Active - adverse effects | Viremia - drug therapy | Viremia - complications | HIV Infections - complications | Aging | Cardiovascular Diseases - epidemiology | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Cardiovascular disease | Patients | Human immunodeficiency virus--HIV
Journal Article
Archives of Virology, ISSN 0304-8608, 11/2016, Volume 161, Issue 11, pp. 3263 - 3268
This study aimed to evaluate the association between the IFNL4 rs368234815 (ΔG/TT) dinucleotide polymorphism and the IFN response during chronic HIV-1...
HIV-1 | IFN | Medical Microbiology | Biomedicine | ISGs | SNP | Infectious Diseases | IFNL4 | Virology | CLEARANCE | CELLS | III INTERFERONS | INNATE | ALPHA | POLYMORPHISM | IL28B | VIROLOGY | HEPATITIS-C VIRUS | INTERFERON-LAMBDA FAMILY | ANTIVIRAL ACTIVITY | Humans | Middle Aged | RNA, Messenger - analysis | Genotype | Male | Gene Expression Profiling | Genotyping Techniques | Polymorphism, Genetic | HIV Infections - immunology | Interleukins - genetics | Leukocytes, Mononuclear - immunology | Adult | Female | Immunologic Factors - biosynthesis | Highly active antiretroviral therapy | Enzymes | RNA | Analysis | Genes | Genetic research | Genetic aspects | HIV (Viruses) | Apolipoproteins | Gene expression | Health aspects
HIV-1 | IFN | Medical Microbiology | Biomedicine | ISGs | SNP | Infectious Diseases | IFNL4 | Virology | CLEARANCE | CELLS | III INTERFERONS | INNATE | ALPHA | POLYMORPHISM | IL28B | VIROLOGY | HEPATITIS-C VIRUS | INTERFERON-LAMBDA FAMILY | ANTIVIRAL ACTIVITY | Humans | Middle Aged | RNA, Messenger - analysis | Genotype | Male | Gene Expression Profiling | Genotyping Techniques | Polymorphism, Genetic | HIV Infections - immunology | Interleukins - genetics | Leukocytes, Mononuclear - immunology | Adult | Female | Immunologic Factors - biosynthesis | Highly active antiretroviral therapy | Enzymes | RNA | Analysis | Genes | Genetic research | Genetic aspects | HIV (Viruses) | Apolipoproteins | Gene expression | Health aspects
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 08/2016, Volume 88, Issue 8, pp. 1347 - 1356
HIV infection may enhance immune‐activation, while little is known regarding the role of HCV infection. This study investigates the impact of HCV in HIV...
HLA‐DR | CD38 | HIV/HCV coinfection | flow cytometry | immune activation | Flow cytometry | Immune activation | HLA-DR | LIVER FIBROSIS | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL-HISTORY | IMPACT | CD4 | HIV-INFECTION | VIROLOGY | HEPATITIS-C VIRUS | DISEASE | PROGRESSION | T-Lymphocyte Subsets - immunology | ADP-ribosyl Cyclase 1 - analysis | HLA-DR Antigens | Hepacivirus - immunology | Humans | Middle Aged | Hepatitis C, Chronic - virology | Male | Viral Load | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Flow Cytometry | HIV-1 - isolation & purification | Adult | Female | Hepacivirus - isolation & purification | Lymphocyte Activation | Coinfection - immunology | HIV Infections - virology | CD4 Lymphocyte Count | Coinfection - virology | Acquired Immunodeficiency Syndrome - drug therapy | Antiretroviral Therapy, Highly Active | HIV-1 - immunology | Phenotype | Hepatitis C, Chronic - immunology | HIV Infections - drug therapy | CD8-Positive T-Lymphocytes - immunology | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | Comorbidity | HIV patients | T cells | Hepatitis C virus | Genotype & phenotype | Antiretroviral drugs | T cell receptors | Human immunodeficiency virus--HIV
HLA‐DR | CD38 | HIV/HCV coinfection | flow cytometry | immune activation | Flow cytometry | Immune activation | HLA-DR | LIVER FIBROSIS | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL-HISTORY | IMPACT | CD4 | HIV-INFECTION | VIROLOGY | HEPATITIS-C VIRUS | DISEASE | PROGRESSION | T-Lymphocyte Subsets - immunology | ADP-ribosyl Cyclase 1 - analysis | HLA-DR Antigens | Hepacivirus - immunology | Humans | Middle Aged | Hepatitis C, Chronic - virology | Male | Viral Load | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Flow Cytometry | HIV-1 - isolation & purification | Adult | Female | Hepacivirus - isolation & purification | Lymphocyte Activation | Coinfection - immunology | HIV Infections - virology | CD4 Lymphocyte Count | Coinfection - virology | Acquired Immunodeficiency Syndrome - drug therapy | Antiretroviral Therapy, Highly Active | HIV-1 - immunology | Phenotype | Hepatitis C, Chronic - immunology | HIV Infections - drug therapy | CD8-Positive T-Lymphocytes - immunology | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | Comorbidity | HIV patients | T cells | Hepatitis C virus | Genotype & phenotype | Antiretroviral drugs | T cell receptors | Human immunodeficiency virus--HIV
Journal Article
Mediators of Inflammation, ISSN 0962-9351, 2015, Volume 2015, pp. 395484 - 11
The complex relationship between both the Th1/Th17 and Tc1/Tc17 axis and innate defences in the intestinal mucosa during HIV-1 infection has not been well...
INTERFERON | T-CELL RESPONSES | THERAPY | MUCOSAL REPAIR | IMMUNODEFICIENCY-VIRUS-INFECTION | VIRAL SUPPRESSION | IN-VIVO | HIV-1-INFECTED PATIENTS | RESTORATION | IMMUNOLOGY | EXPRESSION | CELL BIOLOGY | Humans | Middle Aged | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Lymphoid Tissue - metabolism | Male | Th1 Cells - metabolism | Young Adult | HIV Infections - immunology | Lymphoid Tissue - cytology | Th17 Cells - metabolism | CD8-Positive T-Lymphocytes - metabolism | ADP-ribosyl Cyclase 1 - metabolism | Adult | Studies | Art therapy | Genotype & phenotype | Hospitals | Infectious diseases | Cytokines | Biopsy | Lymphocytes | Infections | Endoscopy | Gene expression | Public health
INTERFERON | T-CELL RESPONSES | THERAPY | MUCOSAL REPAIR | IMMUNODEFICIENCY-VIRUS-INFECTION | VIRAL SUPPRESSION | IN-VIVO | HIV-1-INFECTED PATIENTS | RESTORATION | IMMUNOLOGY | EXPRESSION | CELL BIOLOGY | Humans | Middle Aged | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Lymphoid Tissue - metabolism | Male | Th1 Cells - metabolism | Young Adult | HIV Infections - immunology | Lymphoid Tissue - cytology | Th17 Cells - metabolism | CD8-Positive T-Lymphocytes - metabolism | ADP-ribosyl Cyclase 1 - metabolism | Adult | Studies | Art therapy | Genotype & phenotype | Hospitals | Infectious diseases | Cytokines | Biopsy | Lymphocytes | Infections | Endoscopy | Gene expression | Public health
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2014, Volume 30, Issue 10, pp. 936 - 944
Many sets of data indicate that HIV-infected individuals maintain a low level of chronic immune activation and inflammation even in the presence of effective...
Review Article | INFECTIOUS DISEASES | ITALIAN GUIDELINES | METABOLIC SYNDROME | CHRONIC IMMUNE ACTIVATION | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | VITAMIN-D DEFICIENCY | EXERCISE | VIROLOGY | ANTIRETROVIRAL AGENTS | INFECTED PATIENTS | DIAGNOSTIC-CLINICAL MANAGEMENT | ARTERY-DISEASE | HIV Infections - immunology | Inflammation - complications | Exercise | Humans | HIV Infections - complications | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Inflammation - prevention & control | Review
Review Article | INFECTIOUS DISEASES | ITALIAN GUIDELINES | METABOLIC SYNDROME | CHRONIC IMMUNE ACTIVATION | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | VITAMIN-D DEFICIENCY | EXERCISE | VIROLOGY | ANTIRETROVIRAL AGENTS | INFECTED PATIENTS | DIAGNOSTIC-CLINICAL MANAGEMENT | ARTERY-DISEASE | HIV Infections - immunology | Inflammation - complications | Exercise | Humans | HIV Infections - complications | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Inflammation - prevention & control | Review
Journal Article
Immunity, Inflammation and Disease, ISSN 2050-4527, 09/2017, Volume 5, Issue 3, pp. 244 - 260
Introduction HIV infection is characterized by a persistent immune activation associated to a compromised gut barrier immunity and alterations in the profile...
IELs | HSP60 | GALT | Tc1 | GUT | apoptosis | HIV‐1 | immunity | T‐cell activation | Tc17 | Th1 | Th17 | probiotics | HIV-1 | Immunity | T-cell activation | Probiotics | Apoptosis | HIV-INFECTED INDIVIDUALS | DEPLETION | MUCOSAL | IMMUNOLOGY | INFLAMMATION | DOUBLE-BLIND | DYNAMICS | MICROBIAL TRANSLOCATION | EXPRESSION | INTRAEPITHELIAL LYMPHOCYTES | Probiotics - administration & dosage | Th1 Cells - pathology | CD8-Positive T-Lymphocytes - pathology | Humans | Middle Aged | HIV Seropositivity - drug therapy | Male | Mitochondria - immunology | Mitochondria - pathology | Th1 Cells - immunology | HIV-1 - immunology | Intestinal Mucosa - immunology | Lymphocyte Activation - drug effects | Anti-Retroviral Agents - administration & dosage | Th17 Cells - immunology | Adult | CD8-Positive T-Lymphocytes - immunology | HIV Seropositivity - immunology | HIV Seropositivity - pathology | Intestinal Mucosa - pathology | Th17 Cells - pathology | Antiretroviral drugs | T cell receptors | Human immunodeficiency virus--HIV | Morphology
IELs | HSP60 | GALT | Tc1 | GUT | apoptosis | HIV‐1 | immunity | T‐cell activation | Tc17 | Th1 | Th17 | probiotics | HIV-1 | Immunity | T-cell activation | Probiotics | Apoptosis | HIV-INFECTED INDIVIDUALS | DEPLETION | MUCOSAL | IMMUNOLOGY | INFLAMMATION | DOUBLE-BLIND | DYNAMICS | MICROBIAL TRANSLOCATION | EXPRESSION | INTRAEPITHELIAL LYMPHOCYTES | Probiotics - administration & dosage | Th1 Cells - pathology | CD8-Positive T-Lymphocytes - pathology | Humans | Middle Aged | HIV Seropositivity - drug therapy | Male | Mitochondria - immunology | Mitochondria - pathology | Th1 Cells - immunology | HIV-1 - immunology | Intestinal Mucosa - immunology | Lymphocyte Activation - drug effects | Anti-Retroviral Agents - administration & dosage | Th17 Cells - immunology | Adult | CD8-Positive T-Lymphocytes - immunology | HIV Seropositivity - immunology | HIV Seropositivity - pathology | Intestinal Mucosa - pathology | Th17 Cells - pathology | Antiretroviral drugs | T cell receptors | Human immunodeficiency virus--HIV | Morphology
Journal Article
Clinics and Research in Hepatology and Gastroenterology, ISSN 2210-7401, 09/2018, Volume 42, Issue 4, pp. 319 - 329
Chronic immune activation and poor T-cell immune response are strongly associated with disease progression and pathogenesis of both hepatitis C virus (HCV) and...
Immune activation | T-cell | Hepatitis C virus | Direct-acting antiviral | Intracellular cytokine assay | Human immunodeficiency virus-1 | GAMMA | LIVER INFLAMMATION | PLUS RIBAVIRIN | INTERFERON-FREE THERAPY | VIRUS-INFECTION | CHRONIC HEPATITIS-C | RIBAVIRIN THERAPY | HIV/HCV-COINFECTED PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | INCREASED FREQUENCY | Coinfection | Antiviral Agents - therapeutic use | Lymphocyte Activation | Humans | Middle Aged | Male | Hepatitis C, Chronic - drug therapy | Case-Control Studies | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Flow Cytometry | Hepatitis C, Chronic - immunology | Adult | Female | HIV Infections - drug therapy | CD8-Positive T-Lymphocytes - immunology | Cytokines - blood
Immune activation | T-cell | Hepatitis C virus | Direct-acting antiviral | Intracellular cytokine assay | Human immunodeficiency virus-1 | GAMMA | LIVER INFLAMMATION | PLUS RIBAVIRIN | INTERFERON-FREE THERAPY | VIRUS-INFECTION | CHRONIC HEPATITIS-C | RIBAVIRIN THERAPY | HIV/HCV-COINFECTED PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | INCREASED FREQUENCY | Coinfection | Antiviral Agents - therapeutic use | Lymphocyte Activation | Humans | Middle Aged | Male | Hepatitis C, Chronic - drug therapy | Case-Control Studies | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Flow Cytometry | Hepatitis C, Chronic - immunology | Adult | Female | HIV Infections - drug therapy | CD8-Positive T-Lymphocytes - immunology | Cytokines - blood
Journal Article
Journal of Interferon & Cytokine Research, ISSN 1079-9907, 01/2014, Volume 34, Issue 1, pp. 35 - 40
Interleukin-17 (IL-17) is a pro-inflammatory cytokine that is mainly produced by CD4+ T cells. The role of Th17 during the human immunodeficiency virus (HIV)-1...
Research Reports | IMMUNODEFICIENCY-VIRUS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CYTOKINE | IMMUNOLOGY | HELPER T-CELLS | CELL BIOLOGY | RESPONSES | GROWTH-FACTOR-BETA | IL-17 | HUMAN TH17 CELLS | DIFFERENTIATION | HIV-1 INFECTION | EXPRESSION | Anti-HIV Agents - pharmacology | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Virus Replication - drug effects | HIV Infections - virology | Humans | Interleukin-17 - immunology | Interleukin-15 - antagonists & inhibitors | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Interleukin-17 - biosynthesis | Interleukin-15 - immunology
Research Reports | IMMUNODEFICIENCY-VIRUS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CYTOKINE | IMMUNOLOGY | HELPER T-CELLS | CELL BIOLOGY | RESPONSES | GROWTH-FACTOR-BETA | IL-17 | HUMAN TH17 CELLS | DIFFERENTIATION | HIV-1 INFECTION | EXPRESSION | Anti-HIV Agents - pharmacology | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Virus Replication - drug effects | HIV Infections - virology | Humans | Interleukin-17 - immunology | Interleukin-15 - antagonists & inhibitors | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Interleukin-17 - biosynthesis | Interleukin-15 - immunology
Journal Article
PLOS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0137200
Background HIV infection results in damage to the gastrointestinal (GI) tract, microbial translocation and immune activation. These are not completely...
C-reactive protein | CD8 antigen | Clinical trials | Life assessment | Activation | Lymphocytes T | Immunity | Interleukin 6 | Cell activation | Microorganisms | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | CD38 antigen | Human immunodeficiency virus--HIV | Peripheral blood | Supplementation | Translocation | Antiretroviral drugs | Statistical analysis | Enumeration | Immune response | Complications | Dietary supplements | Markers | Attorneys | Gastrointestinal tract | Inflammation | Ribonucleic acid--RNA | Patients | Morbidity | Antiretroviral therapy | CD4 antigen | Probiotics | Plasma levels | Histocompatibility antigen HLA | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
C-reactive protein | CD8 antigen | Clinical trials | Life assessment | Activation | Lymphocytes T | Immunity | Interleukin 6 | Cell activation | Microorganisms | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | CD38 antigen | Human immunodeficiency virus--HIV | Peripheral blood | Supplementation | Translocation | Antiretroviral drugs | Statistical analysis | Enumeration | Immune response | Complications | Dietary supplements | Markers | Attorneys | Gastrointestinal tract | Inflammation | Ribonucleic acid--RNA | Patients | Morbidity | Antiretroviral therapy | CD4 antigen | Probiotics | Plasma levels | Histocompatibility antigen HLA | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Brain and Behavior, ISSN 2162-3279, 08/2017, Volume 7, Issue 8, pp. e00756 - n/a
Introduction The gut microbiota is involved in the regulation of cognition, mood, anxiety, and pain, and can impact cognitive functions by producing...
miRNA | miRNA‐29 | neuropsychological performance | HIV | probiotics | miRNA-29 | DEPRESSION | BEHAVIOR | MICROBIOTA | NEUROSCIENCES | THERAPY | DISEASE | INFANTIS | GUT-BRAIN AXIS | BEHAVIORAL SCIENCES | NEUROCOGNITIVE DISORDERS | Probiotics - administration & dosage | Anti-Retroviral Agents - therapeutic use | MicroRNAs - cerebrospinal fluid | HIV-1 - drug effects | HIV Infections - virology | Humans | Middle Aged | HIV Infections - psychology | Male | Mental Recall - drug effects | Cognition - drug effects | Neuropsychological Tests | Attention - physiology | Pilot Projects | HIV-1 - isolation & purification | Mental Recall - physiology | Attention - drug effects | Adult | Female | HIV Infections - drug therapy | Dietary Supplements | Antiviral agents | Care and treatment | Safety regulations | MicroRNA | Metabolites | Microbiota (Symbiotic organisms) | Analysis | HIV patients | Anxiety | HIV (Viruses)
miRNA | miRNA‐29 | neuropsychological performance | HIV | probiotics | miRNA-29 | DEPRESSION | BEHAVIOR | MICROBIOTA | NEUROSCIENCES | THERAPY | DISEASE | INFANTIS | GUT-BRAIN AXIS | BEHAVIORAL SCIENCES | NEUROCOGNITIVE DISORDERS | Probiotics - administration & dosage | Anti-Retroviral Agents - therapeutic use | MicroRNAs - cerebrospinal fluid | HIV-1 - drug effects | HIV Infections - virology | Humans | Middle Aged | HIV Infections - psychology | Male | Mental Recall - drug effects | Cognition - drug effects | Neuropsychological Tests | Attention - physiology | Pilot Projects | HIV-1 - isolation & purification | Mental Recall - physiology | Attention - drug effects | Adult | Female | HIV Infections - drug therapy | Dietary Supplements | Antiviral agents | Care and treatment | Safety regulations | MicroRNA | Metabolites | Microbiota (Symbiotic organisms) | Analysis | HIV patients | Anxiety | HIV (Viruses)
Journal Article